Engineered fibrin matrices for functional display of cell membrane-bound growth factor-like activities: Study of angiogenic signaling by ephrin-B2
- 2 December 2003
- journal article
- research article
- Published by Elsevier in Biomaterials
- Vol. 25 (16) , 3245-3257
- https://doi.org/10.1016/j.biomaterials.2003.10.015
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- EphB ligand, ephrinB2, suppresses the VEGF‐ and angiopoietin‐1‐induced Ras/mitogen‐activated protein kinase pathway in venous endothelial cellsThe FASEB Journal, 2002
- Covalently conjugated VEGF–fibrin matrices for endothelializationPublished by Elsevier ,2001
- Development of growth factor fusion proteins for cell‐triggered drug deliveryThe FASEB Journal, 2001
- Regulated Cleavage of a Contact-Mediated Axon RepellentScience, 2000
- Cross-Linking Exogenous Bifunctional Peptides into Fibrin Gels with Factor XIIIaBioconjugate Chemistry, 1998
- Vascular endothelial growth factor and heparin in a biologic glue promotes human aortic endothelial cell proliferation with aortic smooth muscle cell inhibitionSurgery, 1996
- Selective stimulation of endothelial cell proliferation with inhibition of smooth muscle cell proliferation by fibroblast growth factor-1 plus heparin delivered from fibrin glue suspensions*Surgery, 1995
- Improvement of tracheal autograft revascularization by means of fibroblast growth factorThe Annals of Thoracic Surgery, 1994
- Factor XIII‐mediated cross‐linking of NH2‐terminal peptide of α2‐plasmin inhibitor to fibrinFEBS Letters, 1983
- A simple procedure for the long-term cultivation of chicken embryosDevelopmental Biology, 1974